Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) FCF Margin (2016 - 2025)

Cytokinetics (CYTK) has disclosed FCF Margin for 16 consecutive years, with 235.9% as the latest value for Q4 2025.

  • Quarterly FCF Margin changed N/A to 235.9% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 217.7% through Dec 2025, changed N/A year-over-year, with the annual reading at 607.48% for FY2025, 166791.0% down from the prior year.
  • FCF Margin for Q4 2025 was 235.9% at Cytokinetics, up from 8693.1% in the prior quarter.
  • The five-year high for FCF Margin was 63.89% in Q4 2021, with the low at 39207.63% in Q2 2024.
  • Average FCF Margin over 5 years is 8602.65%, with a median of 3469.15% recorded in 2022.
  • The sharpest move saw FCF Margin plummeted -2521317bps in 2024, then soared 702678bps in 2025.
  • Over 5 years, FCF Margin stood at 63.89% in 2021, then plummeted by -7153bps to 4633.67% in 2022, then rose by 4bps to 4432.66% in 2023, then tumbled by -396bps to 22007.34% in 2024, then soared by 99bps to 235.9% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 235.9%, 8693.1%, and 22007.34% for Q4 2025, Q1 2025, and Q3 2024 respectively.